Previous 10 | Next 10 |
Alexandria Real Estate Equities, Inc. Announces Exclusive Partnership With Lilly to Expand Lilly Gateway Labs to San Diego PR Newswire Alexandria and Lilly, which began their strategic relationship in 2008, are collaborating to support and accelerate the development of pro...
Lilly Announces Plans to Open its First-ever Gateway Labs Site in San Diego PR Newswire Scheduled to open in the first half of 2024, Lilly's new Gateway Labs location, in partnership with Alexandria Real Estate Equities, will feature a world-class, state-of-the-art lab facilit...
2023-11-27 13:13:29 ET U.S. President Joe Biden plans to invoke the Defense Production Act of 1950 to build up domestic production of essential drugs, as one of the many actions announced during the first meeting of his new supply chain resilience council. The Cold War-era federal l...
2023-11-27 12:58:26 ET More on Novo Nordisk Novo Nordisk: Plenty More Room To Run Despite Its Hefty Valuation Novo Nordisk: Massive Reality Check Awaits Greedy Investors Novo Nordisk: Healthy Gains Ahead, EPS Growth Seen, Technical Strength Lexaria stock rall...
2023-11-27 12:22:51 ET Mounjaro – a popular treatment for diabetes is more effective for losing weight than Ozempic, as per a large study of real-word data by Truveta Research. FDA recently approved a new named Mounjaro On Monday, the healthcare data analytics firm said p...
2023-11-27 10:44:10 ET Summary The second half of November saw announcements of annual dividend increases from nine companies, including an 11% increase from Nike. Merck’s annual dividend boost will be deferred to December. Widely-held Broadcom and Mastercard will announce ...
2023-11-26 12:00:17 ET More on Centene, CVS Health, etc. A Look At Elevance's Margin Dynamics Centene: Overlooked Healthcare Giant CVS Health: All Eyes On December Investor Day Walgreens stores to close on Thanksgiving for the first time Health Insure...
2023-11-26 06:55:00 ET Are you a pro when it comes to procrastination? Some investors take so long to make a decision on buying stocks that they miss out on great upside moves. And when those stocks pay juicy dividends, they also miss out on income. Three Motley Fool contributors think ...
2023-11-25 14:00:00 ET Summary SCHD fell further after failing to bottom out in July and August 2023. The leading sectors in SCHD underperformed recently as investors rotated out. However, dip buyers have returned with conviction, helping recover all the losses in October. I a...
2023-11-25 09:00:00 ET Summary Novo Nordisk's stock continues to surge as greedy investors exploit surging momentum, as they fear missing out on further potential gains. The company's impressive Q3 earnings results suggest the upward momentum could continue. I also have not assess...
News, Short Squeeze, Breakout and More Instantly...
Lilly's tirzepatide successful in phase 3 study showing benefit in adults with heart failure with preserved ejection fraction and obesity PR Newswire Tirzepatide reduced the risk of heart failure outcomes – heart failure urgent visit or hospitalization , oral diuret...
2024-07-30 07:07:00 ET If your portfolio doesn't have exposure to the biopharma businesses pursuing the development of weight loss medicines, it might be time to consider changing that situation. With an influx of new drugs for sale, and many competitors looking to secure their share of the...
2024-07-30 05:48:00 ET Going into 2024, DexCom 's (NASDAQ: DXCM) shares were up a whopping 14 times over the last 10 years. The company's continuous glucose monitoring (CGM) devices enjoyed tremendous demand from individuals with diabetes. However, last week was the worst for De...